Patients with severe COVID-19 have been found to have significantly higher plasma VWF antigen (VWF:Ag) and activity (VWF:RCo and VWF:CB) levels, which is consistent with the idea that severe COVID-19 is linked to notable endothelial cell activation [117]. Here, VWF is linked to COVID-19.